Evidence map›Paper›PMID 40894901›Full record

ReviewiScience2025

The role of taurine in bone metabolism.

Xier Chen, Yingge Yuan, Xuchang Zhou, Huili Deng, Jun Zhang, Shuning Duan, Guoxin Ni

Abstract readReview
In one paragraph

Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xier ChenSchool of Sports Medicine, Wuhan Sports University, Wuhan 430079, China.
Yingge YuanDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
Xuchang ZhouSchool of Sport Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China.
Huili DengSchool of Medicine, Xiamen University, Xiamen 361102, China.
Jun ZhangDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
Shuning DuanSchool of Sports Medicine, Wuhan Sports University, Wuhan 430079, China.
Guoxin NiDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metabolism is a dynamic process involving remodeling and rebuilding bone tissue. Important participants in this process include osteoblasts and osteoclasts, which may promote bone formation and bone resorption, respectively. Cumulative evidence suggests that taurine, a sulfur-containing nonessential amino acid, can regulate bone formation, bone resorption, and bone immunity through anti-inflammatory and antioxidant properties in bone metabolic diseases. However, the potential mechanisms by which taurine regulates bone metabolism remain unclear. This review focuses on the potential role of taurine in bone metabolic diseases, particularly osteoporosis and rheumatoid arthritis. Moreover, the regulatory mechanisms of taurine on bone formation, bone resorption, and bone immunity are summarized, which provides a theoretical basis for the application of taurine as a therapeutic agent to improve bone metabolic diseases.

Indexed as

Biological sciencesNatural sciencesPhysiology

Identifiers

PMID40894901
PMCPMC12391252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.